|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1999-9-8
|
|
pubmed:abstractText |
Carriers of the mutations 185delAG and 5382insC in the BRCA1 gene and 6174delT in the BRCA2 gene have a substantial life-time risk for breast and ovarian cancers (BC and OC). The aim of the study was to identify the clinical features and the hormonal risk modifiers in mutation carriers and the implication in suggested guidelines for treatment decisions in BRCA1/2 carrier patients.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0301-2115
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
85
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
75-80
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:10428326-Adult,
pubmed-meshheading:10428326-Age Factors,
pubmed-meshheading:10428326-Aged,
pubmed-meshheading:10428326-BRCA2 Protein,
pubmed-meshheading:10428326-Breast Neoplasms,
pubmed-meshheading:10428326-Female,
pubmed-meshheading:10428326-Genes, BRCA1,
pubmed-meshheading:10428326-Heterozygote Detection,
pubmed-meshheading:10428326-Humans,
pubmed-meshheading:10428326-Menarche,
pubmed-meshheading:10428326-Menopause,
pubmed-meshheading:10428326-Middle Aged,
pubmed-meshheading:10428326-Mutation,
pubmed-meshheading:10428326-Neoplasm Proteins,
pubmed-meshheading:10428326-Ovarian Neoplasms,
pubmed-meshheading:10428326-Pregnancy,
pubmed-meshheading:10428326-Transcription Factors
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Genetic testing of breast and ovarian cancer patients: clinical characteristics and hormonal risk modifiers.
|
|
pubmed:affiliation |
Sharett Institute of Oncology, Hadassah Hebrew University Hospital, Ein Kerem, Jerusalem, Israel.
|
|
pubmed:publicationType |
Journal Article
|
